Meigs’ syndrome with elevated CA-125 and HE-4: a case report and literature review
Jichang Seong,
No information about this author
Abdusattorov Ravshan,
No information about this author
Sametdinov Narkhodzha
No information about this author
et al.
Frontiers in Medicine,
Journal Year:
2025,
Volume and Issue:
12
Published: Feb. 24, 2025
Meigs'
syndrome
is
a
rare
gynecological
condition
characterized
by
benign
ovarian
tumor,
ascites,
and
pleural
effusion,
all
of
which
resolve
spontaneously
after
tumor
removal.
While
mildly
elevated
serum
CA-125
levels
are
frequently
observed,
exceeding
1,000
IU/mL
extremely
rare,
concurrent
elevation
other
markers,
such
as
HE-4,
may
further
complicate
its
diagnosis.
We
report
case
in
41-year-old
premenopausal
woman.
Initial
presenting
symptoms
included
severe
dyspnea,
abdominal
distention,
anorexia,
weight
loss.
Subsequent
imaging
studies
revealed
large
right
accompanied
massive
ascites
effusion.
Serum
HE-4
were
markedly
(1,200
82.1
pmol/L,
respectively),
with
Risk
Ovarian
Malignancy
Algorithm
(ROMA)
score
25.63%,
suggesting
advanced
malignancy.
Neoadjuvant
chemotherapy
was
initiated,
but
the
continued
to
grow,
necessitating
internal
debulking
surgery.
Postoperative
histopathology
fibroma,
confirming
diagnosis
syndrome.
Spontaneous
resolution
effusion
occurred
second
postoperative
day,
markers
normalized
within
next
six
months.
The
patient
remained
disease-free
at
2-year
follow-up.
This
underscores
importance
considering
patients
an
unresponsive
chemotherapy,
concomitant
Early
recognition
surgical
intervention
critical
for
accurate
optimal
management
this
condition.
Language: Английский
The Role of CA‐125 in the Management of Ovarian Cancer: A Systematic Review
Cancer Reports,
Journal Year:
2025,
Volume and Issue:
8(3)
Published: March 1, 2025
ABSTRACT
Background
Ovarian
cancer
is
frequently
occurring
and
fatal
for
women.
CA‐125
important
in
the
screening,
diagnosis,
treatment
of
ovarian
cancer.
This
review
study
was
conducted
to
explore
influence
addressing
Methods
To
investigate
role
cancer,
we
a
comprehensive
search
high‐quality
articles
Medline,
Web
Science
Core
Collection
Scopus
databases
using
keywords
“ovarian
cancer,”
carcinoma,”
neoplasms,”
“CA‐125”
from
2000
2024.
We
included
full‐text,
peer‐reviewed
English
with
relevant
published
since
2000.
excluded
case
reports,
commentaries,
letters
editor,
books,
series,
systematic
reviews,
animal
studies,
that
were
not
accessible
full
text.
Results
After
screening
7947
records,
88
studies
this
review.
In
literature
review,
it
found
researchers
utilized
diagnosing
its
predicting,
evaluating
response,
assessing
survival,
early
detection
recurrence.
some
cases,
employed
additional
tumor
markers
alongside
enhance
test's
sensitivity.
Conclusion
has
become
pivotal
marker
Its
treatment,
ongoing
assessment
cannot
be
overstated.
Continuous
monitoring
levels
can
provide
insights,
categorizing
patients
as
low‐risk
or
high‐risk
based
on
could
lead
better
outcomes.
Integrating
other
biomarkers
may
accuracy
test
elevate
relevance
patient
care.
Language: Английский
Cisplatin Resistance and Metabolism: Simplification of Complexity
Cancers,
Journal Year:
2024,
Volume and Issue:
16(17), P. 3082 - 3082
Published: Sept. 4, 2024
Cisplatin
is
one
of
the
most
well-known
anti-cancer
drugs
and
has
demonstrated
efficacy
against
numerous
tumor
types
for
many
decades.
However,
a
key
challenge
with
cisplatin,
as
any
chemotherapeutic
agent,
development
resistance
resultant
loss
efficacy.
This
often
associated
metabolic
alterations
that
allow
insensitive
cells
to
divide
survive
under
treatment.
These
adaptations
could
vary
greatly
among
different
may
seem
questionable
incomprehensible
at
first
glance.
Here
we
discuss
disturbances
in
glucose,
lipid,
amino
acid
metabolism
cisplatin-resistant
well
roles
ferroptosis
autophagy
acquiring
this
type
drug
intolerance.
Language: Английский
Exploring Radioiodinated Anastrozole and Epirubicin as AKT1-Targeted Radiopharmaceuticals in Breast Cancer: In Silico Analysis and Potential Therapeutic Effect with Functional Nuclear Imagining Implications
Mazen Abdulrahman Binmujlli
No information about this author
Molecules,
Journal Year:
2024,
Volume and Issue:
29(17), P. 4203 - 4203
Published: Sept. 4, 2024
This
study
evaluates
radio-iodinated
anastrozole
([125I]anastrozole)
and
epirubicin
([125I]epirubicin)
for
AKT1-targeted
breast
cancer
therapy,
utilizing
radiopharmaceutical
therapy
(RPT)
personalized
treatment.
Through
molecular
docking
dynamics
simulations
(200
ns),
it
investigates
these
compounds’
binding
affinities
mechanisms
to
the
AKT1
enzyme,
compared
co-crystallized
ligand,
a
known
inhibitor.
Molecular
results
show
that
[125I]epirubicin
has
highest
ΔGbind
(−11.84
kcal/mol),
indicating
superior
affinity
[125I]
(−10.68
kcal/mol)
ligand
(−9.53
kcal/mol).
(MD)
confirmed
stable
interaction
with
[125I]anastrozole
reaching
stability
after
approximately
68
ns
an
average
RMSD
of
around
2.2
Å,
while
stabilized
at
2.69
Å
87
ns.
RMSF
analysis
showed
no
significant
shifts
in
residues
or
segments,
consistent
patterns
differences
less
than
2
maintaining
enzyme
stability.
The
complex
maintained
four
H-bonds,
strong
interactions,
consistently
formed
three
H-bonds.
Rg
values
both
complexes
were
~16.8
±
0.1
changes
enzyme’s
compactness,
thus
preserving
structural
integrity.
These
analyses
reveal
minimal
perturbations,
suggesting
high
potential
inhibition.
MM-PBSA
calculations
confirm
compounds
as
inhibitors,
exhibiting
most
favorable
energy
(−23.57
0.14
(−20.03
0.15
(−16.38
highlighting
role
electrostatic
interactions
stabilizing
complex.
computational
shows
may
play
promising
roles
especially
its
dynamic
receptor
interactions.
findings,
supported
by
scores
energies,
advocate
their
inhibitory
capability
against
enzyme.
Nevertheless,
is
crucial
validate
predictions
through
vitro
vivo
studies
thoroughly
evaluate
therapeutic
viability
Language: Английский
The Role of the Plasminogen Activator Inhibitor 1 (PAI1) in Ovarian Cancer: Mechanisms and Therapeutic Implications
Sneha Grace Mathews,
No information about this author
Rajesh Krishna,
No information about this author
M Lavanya
No information about this author
et al.
Global Medical Genetics,
Journal Year:
2024,
Volume and Issue:
11(04), P. 358 - 365
Published: Oct. 29, 2024
Ovarian
cancer
(OC)
is
one
among
most
significantly
fatal
gynecological
cancers,
with
late-stage
detection
and
an
inadequate
prognosis.
Plasminogen
activator
inhibitor-1
(
Language: Английский
Activity of NAD(P)H-Oxidoreductases in Ovarian Cancer
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(5), P. 1052 - 1052
Published: May 10, 2024
Reactive
oxygen
species
(ROS)
play
an
important
and
controversial
role
in
carcinogenesis.
Microsomal
redox
chains
containing
NADH-
NADPH-dependent
oxidoreductases
are
among
the
main
sites
of
intracellular
ROS
synthesis,
but
their
oxidative
balance
has
not
been
fully
studied.
Here,
we
studied
activity
cytochrome
b5
reductase
(CYB5R)
P450
(CYPOR)
ovarian
cancer
tissues
cells
isolated
from
peritoneal
fluid,
along
with
antioxidant
capacity
fluid.
We
used
developed
a
chemiluminescence
assay
based
on
stimulation
NADH
NADPH,
which
reflects
CYB5R
CYPOR,
respectively.
The
CYPOR
was
significantly
higher
moderately
poorly
differentiated
adenocarcinomas
compared
well-differentiated
cystadenomas.
For
chemotherapy-resistant
tumors,
tissue
lower
to
non-resistant
tumors.
In
increased
this
series,
benign
tumors
<
adenocarcinomas,
so
excess
observed
for
adenocarcinomas.
fluid
were
characterized
by
direct
moderate
correlation
These
results
indicate
significant
NAD(P)H
potential
biochemistry.
parameters
useful
diagnostics
prognostics.
can
be
analyze
other
cells.
Language: Английский
Genomic instability in ovarian cancer: Through the lens of single nucleotide polymorphisms
Harshavardhani Canchi Sistla,
No information about this author
Srikanth Talluri,
No information about this author
Taruna Rajagopal
No information about this author
et al.
Clinica Chimica Acta,
Journal Year:
2024,
Volume and Issue:
565, P. 119992 - 119992
Published: Oct. 10, 2024
Language: Английский
Prognostic Relevance of Copy Number Losses in Ovarian Cancer
Genes,
Journal Year:
2024,
Volume and Issue:
15(11), P. 1487 - 1487
Published: Nov. 19, 2024
Aneuploidy
is
a
prevalent
cancer
feature
that
occurs
in
many
solid
tumors.
For
example,
high-grade
serous
ovarian
shows
high
level
of
copy
number
alterations
and
genomic
rearrangements.
This
makes
variants
appealing
as
diagnostic
or
prognostic
biomarkers,
well
for
their
easy
detection.
In
this
study,
we
focused
on
(CN)
losses
shared
by
stem
cells
(CSCs)
to
identify
chromosomal
regions
may
be
important
CSC
features
and,
turn,
patients'
prognosis.
Language: Английский
Diagnostic Utility of Metalloproteinases from Collagenase Group (MMP-1, MMP-8 and MMP-13) in Biochemical Diagnosis of Ovarian Carcinoma
Cancers,
Journal Year:
2024,
Volume and Issue:
16(23), P. 3969 - 3969
Published: Nov. 26, 2024
Ovarian
carcinoma
(OC)
has
an
unfavorable
prognosis
due
to
lack
of
screening
and
asymptomatic
course.
New
diagnostic
methods
are
being
sought
enable
earlier
diagnosis
this
condition.
The
purpose
study
was
determine
the
utility
collagenases
(MMP-1,
MMP-8
MMP-13)
in
OC
compared
HE4
CA125
ROMA.
Language: Английский